| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |